Related Experiment Video
Updated: Oct 17, 2025
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
[Enhanced Autophagy Suppresses Proplatelet Formation in Pediatric Immune Thrombocytopenia]
1Department of Clinical Laboratory Examination, Children's Hospital of Soochow University, Suzhou 215025, Jiangsu Province, China.
Insights
Enhanced autophagy in children with immune thrombocytopenia (ITP) impairs megakaryocyte proplatelet formation. This study reveals autophagy
Area of Science:
- Hematology
- Cell Biology
- Molecular Medicine
Background:
- Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low platelet counts.
- Megakaryocytes are bone marrow cells responsible for platelet production.
- Autophagy is a cellular degradation process that plays a role in various physiological and pathological conditions.
Purpose of the Study:
- To investigate the role of enhanced autophagy in megakaryocyte proplatelet formation in children with ITP.
- To explore the molecular mechanisms underlying impaired proplatelet formation in ITP.
Main Methods:
- Giemsa and immunofluorescence staining to assess megakaryocyte morphology and proplatelet formation.
- Western blot analysis to determine the expression of cytoskeleton and autophagy-related proteins.
- In vitro experiments using autophagy regulators (Rapamycin and 3-MA) to modulate autophagy in megakaryocytes.
Main Results:
- ITP megakaryocytes exhibited vacuole-like structures and significantly higher expression of autophagy markers (LC3II/I and Atg5-Atg12) compared to controls.
- Abnormal cytoskeleton arrangement and increased myosin light chain phosphorylation were observed in ITP megakaryocytes.
- Autophagy modulation in vitro affected proplatelet production and the expression of cell cycle-related proteins (CyclinD1, CyclinD2, P21).
Conclusions:
- Enhanced autophagy is a critical factor contributing to impaired proplatelet formation in pediatric ITP.
- Autophagy dysregulation impacts megakaryocyte function and platelet production in ITP.
Objective:
To investigate the effect of enhanced autophagy in megakaryocyte to proplatelet formation in children with immune thrombocytopenia(ITP).
Methods:
Giemsa staining and immunofluorescence staining were used to observe megakaryocyte morphology and proplatelet formation, Western blot was used to determine the expression of cytoskeleton protein and autophagy related protein. Autophagr regulation drugs Rap or 3-MA was used to regulate autophagy of megakaryocytes.
Results:
Some vacuole-like structures was found in ITP megakaryocytes of the children, the expression of LC3II/I (ITP 1.32±0.18； Ctrl 0.49±0.16，P<0.05) and Atg5-Atg12 (ITP 0.69±0.17； Ctrl 0.12±0.08，P<0.05) was significantly higher in ITP children as compared with those in control group. The immu- nofluorescence staining showed that the cytoskeleton arrangement in megakaryocytes of ITP children was abnormal, and the phosphorylation of myosin light chain was also increased(ITP 0.74±0.09, Ctrl 0.05±0.02，P<0.05). In vitro, inducer or inhibitor of autophagy could regulate the production of proplatelet and the expression of cell cycle related protein, including CyclinD1（Veh 1.08±0.12; Rap 0.46±0.04; Rap+3-MA 0.70±0.03）, CyclinD2（Veh 0.47±0.04; Rap 0.27±0.04; Rap+3-MA 0.41±0.03）, P21（Veh 0.15±0.01; Rap 0.04±0.01; Rap+3-MA 0.05±0.01）.
Conclusion:
Enhanced autophagy is the key factor of poor proplatelet formation in megakaryocytes of ITP children.
More Related Videos
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Related Concept Videos
01:18Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:22Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...